Glabridin and gymnemic acid alleviates choroid structural change and choriocapillaris impairment in diabetic rat’s eyes

Table 3 A comparison of the body weight in different groups

Week	C (g)	DM (g)	DM + GB (g)	DM + GM (g)	DM + GR (g)
1	256.66 ± 5.25	178.83 ± 3.565	173.33 ± 4.715	240.83 ± 4.241	197.66 ± 8.245
2	286.50 ± 6.17	187.33 ± 5.525	181.16 ± 5.935	216.38 ± 10.033	221.33 ± 14.332
3	305.66 ± 8.55	178.83 ± 7.605	181.00 ± 8.095	232.33 ± 8.133	215.50 ± 19.721
4	325.50 ± 8.17	167.50 ± 10.455	179.16 ± 9.155	231.66 ± 9.194	211.33 ± 11.814
5	342.66 ± 9.02	171.83 ± 12.389	166.50 ± 13.52	263.33 ± 15.158	212.16 ± 10.286
6	352.50 ± 8.01	173.50 ± 11.019	179.16 ± 13.28	267.50 ± 15.318	209.33 ± 7.856
7	370.50 ± 8.66	159.50 ± 13.529	175.50 ± 13.04	275.83 ± 16.868	199.00 ± 8.036
8	371.00 ± 9.27	182.00 ± 13.829	191.00 ± 14.61	286.66 ± 18.287	222.83 ± 6.256

¹P < 0.1 compared with control group.

²P < 0.01 compared with control group.

³P < 0.001 compared with control group.

⁴P < 0.0001 compared with control group.

⁵P < 0.000001 compared with control group.

⁶P < 0.1 compared with diabetic group.

⁷P < 0.01 compared with diabetic group.

⁸P < 0.001 compared with diabetic group.

⁹P < 0.000001 compared with diabetic group.

C: Control; DM: Diabetic; DM + GB: Diabetic rats treated with glabridin 40 mg/kg body weight; DM + GM: Diabetic rats treated with gymnemic acid 400 mg/kg body weight; DM + GR: Diabetic rats treated with glyburide 4 mg/kg body weight.